All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Reported results | 2004-001331-36 | A randomized phase III study of follow up with or without adjuvant Gefitinib (IressaTM) following chemotherapy in patients with advanced non-small cell lung cancer | 2009-12-02 | due-trials |
Completed, but no date, and reported results | 2004-004158-23 | DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL ON THE USE OF ACETYL-L-CARNITINE FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) | bad-data | |
Reported results | 2004-004525-99 | A randomized, prospective, double-blind study to evaluate the effects on lipid profile of combined Ezetimibe and Simvastatin therapy as compared to Simvastatin alone in people with type 2 diabetes | 2007-06-21 | due-trials |
Completed, but no date, and reported results | 2005-004598-20 | Clinical study of the association between n-3 PUFA and statin effects on inflammation and lipids. | bad-data | |
Reported results | 2005-005552-41 | Effect of long-acting somatostatin on disease progression in nephropathy due to autosomal dominant polycystic disease a long-term three year follow-up study | 2012-01-26 | due-trials |
Reported results | 2006-003427-37 | Sirolimus treatment in patients with autosomal dominant polycystic kidney disease renal efficacy and safety | 2009-07-24 | due-trials |
Reported results | 2006-005604-14 | A randomized, prospective, multicenter trial to compare the effect on chronic allograft nephropathy prevention of mycophenolate mofetil versus azathioprine as the sole immunosuppressive therapy for k... | 2017-11-29 | due-trials |
Reported results | 2006-005951-14 | A prospective, randomised, open-label blinded end point (PROBE) trial to evaluate, whether, at comparable blood pressure control, combined therapy with the ACE inhibitor benazepril and the angiotensin... | 2016-04-01 | due-trials |
Reported results | 2006-005954-62 | A prospective, randomized, open label blinded end point probe trial to evaluate whether, at comparable blood pressure control, combined therapy with the ACE inhibitor Benazepril and the angiotensin ... | 2018-06-28 | due-trials |
Ongoing | 2007-000278-22 | GiSAS trial aripiprazole, olanzapine and haloperidol in the long term treatment of schizophrenia. | not-yet-due | |
Other | 2007-004917-33 | A Randomised Phase III Trial Comparing Concurrent Chemoradiation and Adjuvant Chemotherapy with Pelvic Radiation Alone in High Risk and Advanced Stage Endometrial Carcinoma | not-yet-due | |
Reported results Terminated | 2007-005047-21 | Effects of Sirolimus on disease progression in patients with Autosomal Dominant Polycystic Kidney Disease and severe renal insufficiency | 2012-07-16 | due-trials |
Reported results | 2007-005925-31 | A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFECT OF 6-MONTH ACETYLCARNITINE THERAPY ON ARTERIAL BLOOD PRESSURE, LIPID AND METABOLIC PROFILE, AND KIDNEY FUNCTION... | 2012-03-26 | due-trials |
Reported results | 2008-000822-38 | A PROSPECTIVE, RANDOMIZED, OPEN LABEL BLINDED END POINT (PROBE), CROSS-OVER STUDY TO COMPARE THE EFFECTS OF TELMISARTAN AND LOSARTAN ON METABOLIC PROFILE OF RENAL TRANSPLANT PATIENTS Studio prospet... | 2013-03-08 | due-trials |
Reported results | 2008-003529-17 | A PROSPECTIVE, RANDOMIZED, OPEN LABEL, BLINDED END-POINT (PROBE) TRIAL TO EVALUATE WHETHER, AT COMPARABLE BLOOD PRESSURE CONTROL, ACE INHIBITOR THERAPY MORE EFFECTIVELY THAN NON RAS INHIBITOR THERAPY ... | 2016-04-27 | due-trials |
Reported results | 2008-006380-36 | A PROSPECTIVE, PILOT, CROSS-OVER STUDY TO ASSESS THE EFFICACY OF PARICALCITOL IN REDUCING PARATHYROID HORMONE LEVELS AND AMELIORATING MARKERS OF BONE REMODELLING IN RENAL TRANSPLANT RECIPIENTS WITH SE... | 2012-07-23 | due-trials |
Reported results | 2008-006750-17 | A prospective, sequential study to assess the efficacy of rituximab therapy in maintaining remission of nephrotic syndrome after steroid and immunosuppressive therapy withdrawal in patients with stero... | 2012-07-16 | due-trials |
Reported results | 2009-011116-38 | Efficacy of nebulised beclometasone versus placebo in preventing viral wheezing in pre-school children | 2012-10-02 | due-trials |
Reported results Terminated | 2009-012376-27 | EFFECTS OF LONG-ACTING SOMATOSTATIN ON DISEASE PROGRESSION IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE AND MODERATE/SEVERE RENAL INSUFFICIENCY(ALADIN II STUDY) | 2010-12-01 | due-trials |
Completed, but no date Terminated | 2009-013340-36 | PREVENTION OF REPERFUSION INJURY IN HUMAN LUNG TRANSPLANTATION FOR CYSTIC FIBROSIS BY TARGETING IL-8 ACTIVITY | bad-data | |
Ongoing | 2009-016017-24 | A PHASE II RANDOMIZED NON COMPARATIVE STUDY ON THE ACTIVITY OF TRABECTEDIN OR GEMCITABINE + DOCETAXEL IN METASTATIC OR LOCALLY RELAPSED UTERINE LEIOMYOSARCOMA PRETREATED WITH CONVENTIONAL CHEMOTHER... | not-yet-due | |
Completed, but no date | 2010-019126-13 | A PILOT, EXPLORATIVE STUDY TO IDENTIFY CONTRAST-ENHANCED ULTRASOUND (CE-US) PATTERNS THAT CHARACTERIZE ACUTE ALLOGRAFT REJECTION AND OTHER CAUSES OF ACUTE ALLOGRAFT DYSFUNCTION IN RENAL TRANSPLANT REC... | bad-data | |
Completed, but no date, and reported results | 2010-021017-23 | RCT comparing the analgesic efficacy of 4 therapeutic strategies based on 4 different major opioids (fentanyl, oxycodone, buprenorphine vs morphine) in cancer patients with moderate/severe pain, at th... | bad-data | |
Reported results Terminated | 2010-021052-25 | ITACA-S 2 (Intergroup Trial in Adjuvant Chemotherapy for Adenocarcinoma of the Stomach): comparison of the efficacy of a peri-operative versus a post-operative chemotherapy treatment in patients wi... | 2013-12-31 | due-trials |
Completed, but no date Terminated | 2010-022021-15 | RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III, SUPERIORITY TRIAL TO ASSESS THE EFFICACY AND SAFETY OF ACETYL-L-CARNITINE IN COMBINATION WITH A C... | bad-data | |
Ongoing | 2010-022233-28 | Fatal familial insomnia: preventive treatment with doxycycline of at risk individuals Insonnia Fatale Familiare: trattamento preventivo con doxiciclina in soggetti a rischio | not-yet-due | |
Listed as ongoing, but also has a completion date | 2010-022949-17 | A Phase III international, randomized study with Trabectedin plus Pegylated Liposomal Doxorubicin (PLD) versus Carboplatin plus PLD in patients with ovarian cancer progressing within 6-12 months of la... | 2020-12-17 | bad-data |
Reported results Terminated | 2010-024431-17 | A PILOT STUDY TO EVALUATE THE INCIDENCE OF HYPONATREMIA IN A MEDICAL-SURGICAL HOSPITAL AND TO EXPLORE THE EFFICACY AND SAFETY OF TOLVAPTAN IN THE CLINICAL PRACTICE STUDIO PILOTA PER VALUTARE L'IN... | 2012-07-26 | due-trials |
Reported results | 2011-000138-12 | A prospective, randomized, double-blind, placebo controlled clinical trial to assess the effects of long-acting somatostatin (Octreotide LAR)therapy on disease progression in patients with Autosomal D... | 2017-10-18 | due-trials |
Completed, but no date Terminated | 2011-000785-35 | A PROSPECTIVE STUDY TO ASSESS THE INTERACTION BETWEEN PATIENT GENOTYPE AND ROSTAFUROXIN EFFECTS ON ARTERIAL BLOOD PRESSURE AND KIDNEY FUNCTION IN NEVER-TREATED HYPERTENSIVE TYPE 2 DIABETES PATIENTS (... | bad-data | |
Reported results | 2011-001713-14 | A PROSPECTIVE, RANDOMIZED, CROSS-OVER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE ANTIPROTEINURIC EFFECT OF SELECTIVE VITAMIN D RECEPTOR ACTIVATION BY PARICALCITOL IN TYPE 2 DIABETES PATIENT... | 2015-05-29 | due-trials |
Reported results | 2011-002876-18 | CYCLosporinE A in reperfused acute myocardial infarction (CYCLE-Trial) Ciclosporina A nell'infarto miocardico acuto riperfuso (studio CYCLE) | 2014-11-17 | due-trials |
Ongoing | 2011-006330-16 | ATREUS TRIAL A PHASE II STUDY ON THE ACTIVITY OF TRABECTEDIN IN PRETREATED EPITHELIOID OR BIPHASIC/SARCOMATOID MALIGNANT PLEURAL MESOTHELIOMA (MPM) STUDIO DI FASE II SULL'ATTIVITA' DELLA TRABECTE... | not-yet-due | |
Completed, but no date, and reported results | 2012-003618-15 | Multicenter, randomized, non-comparative, open-label phase II trial on the efficacy of Ortataxel and Fotemustine in recurrent glioblastoma Studio clinico multicentrico, italiano, randomizzato, non-... | bad-data | |
Ongoing | 2012-003866-42 | Multicenter, randomized, non-comparative, open-label phase II trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in adult women with platin... | not-yet-due | |
Reported results | 2012-005416-26 | A Prospective, Randomized, Open, Blinded Endpoint (PROBE), Clinical Trial to Assess The Renal and Humoral Effects of Sevelamer Carbonate in Patients with Chronic Kidney Disease and Residual Proteinuri... | 2015-09-21 | due-trials |
Reported results | 2013-003826-10 | EVALUATING THE MORPHOFUNCTIONAL EFFECTS OF ECULIZUMAB THERAPY IN PRIMARY MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS: A PILOT, SINGLE ARM STUDY IN TEN PATIENTS WITH PERSISTENT HEAVY PROTEINURIA TE... | 2017-12-19 | due-trials |
Ongoing | 2014-002508-26 | Outcome-related factors in patients with metastatic renal cell carcinoma treated with everolimus after failure of a first-line treatment with VEGF inhibitor Fattori associati all’esito in pazienti ... | not-yet-due | |
Ongoing | 2014-004194-16 | A multicenter, single-arm, phase II study to evaluate the activity of pre-operative zoledronate in triple negative breast cancer patients, according to p53 level | not-yet-due | |
Reported results Terminated | 2014-004261-24 | AN OPEN-LABEL PHASE 2 STUDY TO ASSESS THE EFFECT OF C5AR ANTAGONIST THERAPY BY CCX168 ORAL ADMINISTRATION ON EX VIVO THROMBUS FORMATION AND DISEASE ACTIVITY IN ESRD PATIENTS WITH ATYPICAL HEMOLYTIC U... | 2017-02-24 | due-trials |
Completed, but no date Terminated | 2015-003278-34 | A RANDOMIZED, CROSS-OVER, BIOEQUIVALENCE STUDY OF EFAVIRENZ TABLETS 600 mg OF MYLAN SpA AND SUSTIVA® (EFAVIRENZ) TABLETS 600 mg OF BRISTOL MYERS SQUIBB AT STEADY STATE IN PATIENTS WITH HIV-1 STUDIO... | bad-data | |
Completed, but no date | 2016-000617-67 | A phase II study to investigate the activity and safety of anti-PD-L1 antibody (Durvalumab) In ADvancEd pretreated malignant pleural Mesothelioma - DIADEM Study A phase II study to investigate the ... | bad-data | |
Exempt | 2016-000661-23 | NOVEL STROMAL CELL THERAPY FOR DIABETIC KIDNEY DISEASE (NEPHSTROM Study) | not-yet-due | |
Reported results Terminated | 2016-001864-12 | An international, multicenter, phase II, randomized, parallel-arm trial investigating the role of two different metronomic chemotherapy regimens in locally advanced or metastatic triple negative breas... | 2018-07-23 | due-trials |
Ongoing | 2016-002382-62 | The effects of RNS60 on ALS biomarkers L'effetto del farmaco RNS60 sui biomarcatori della SLA | not-yet-due | |
Completed, but no date | 2016-003964-38 | The BAROCCO study (Best Approach in Recurrent-Ovarian-Cancer-with Cediranib-Olaparib): an Italian multicenter randomized phase II study of weekly paclitaxel vs. Cediranib-Olaparib with continuous sch... | bad-data | |
Ongoing | 2016-005112-17 | Multicenter, randomized, phase II study of neoadjuvant chemotherapy associated or not with zoledronate and atorvastatin in triple negative breast cancers - YAPPETIZER Study Studio multicentrico, ra... | not-yet-due | |
Ongoing | 2017-003595-30 | Treat_CCM Clinical Trial. A multicenter randomized clinical trial on Propranolol in Cerebral Cavernous Malformation Studio multicentrico, randomizzato sul propranololo nella Malformazione Cavernosa... | not-yet-due | |
Ongoing | 2017-004701-40 | A PILOT, PHASE II STUDY WITH A PROSPECTIVE, RANDOMIZED, CROSS-OVER, PLACEBO-CONTROLLED, DOUBLE-BLIND DESIGN TO ASSESS THE SHORT-TERM EFFECTS OF TOLVAPTAN PLUS PLACEBO VS TOLVAPTAN PLUS OCTREOTIDE LAR... | not-yet-due | |
Ongoing | 2018-000781-10 | EFFICACY AND TOLERABILITY OF LOW VS. STANDARD DAILY DOSES OF ANTIEPILEPTIC DRUGS IN NEWLY DIAGNOSED, PREVIOUSLY UNTREATED EPILEPSY (STANDLOW). A MULTICENTER, RANDOMIZED, SINGLE-BLIND, PARALLEL GROUP T... | not-yet-due | |
Completed, but no date Terminated | 2018-001057-26 | Management of the patient with heart failure and diabetes: may insulin be a problem? A pilot randomized clinical study (Insulin-HF). Trattamento del paziente con insufficienza cardiaca e diabete: l... | bad-data | |
Other | 2018-001072-37 | AtTEnd: Atezolizumab Trial in Endometrial cancer - Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with paclitaxel and carboplatin in women with advanced/recu... | not-yet-due | |
Ongoing | 2018-001856-36 | A RANDOMIZED PHASE 2 CLINICAL TRIAL TO EVALUATE THE ACTIVITY OF ATRA IN COMBINATION WITH ANASTROZOLE IN PRE-OPERATIVE PHASE OF OPERABLE HR-POSITIVE/HER2-NEGATIVE EARLY BREAST CANCER EBC ATRA TRIAL ... | not-yet-due | |
Exempt | 2018-003047-32 | CardioPulmonary resuscitation with Argon (CPAr) trial Rianimazione CardioPolmonare con Argon – Studio CPAr | not-yet-due | |
Ongoing | 2018-003736-77 | A MULTICENTER, OPEN-LABEL PHASE II TRIAL OF A NEW CUSTOMIZED DOSING (RATIONAL ADJUSTMENT OF DOSE TO REDUCE ADVERSE REACTIONS “RADAR” DOSING) OF NIRAPARIB AS MAINTENANCE THERAPY IN PLATINUM SENSITIVE O... | not-yet-due | |
Reported results Terminated | 2018-004382-13 | A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF CEMDISIRAN (ALN-CC5) FOLLOWING WITHDRAWAL OF CHRONIC ECULIZUMAB THERAPY IN PATIENTS WITH ATYPICA... | 2020-11-05 | due-trials |
Ongoing | 2019-004025-24 | BRIDGE trial: Phase II trial of durvalumaB and chemotheRapy Induction followed by Durvalumab and radiotherapy in larGe volumE stage III NSCLC Essai BRIDGE : Essai de phase II sur le Durvalumab et l... | not-yet-due | |
Ongoing, reported early | 2019-004152-10 | Evaluating the Short-Term Renal and Systemic Effects of SGLT2 Inhibition in Non-Diabetic Patients at Risk of Accelerated GFR Decline Because of Glomerular Hyperfiltration: a sequential OFF-ON-OFF Stud... | not-yet-due | |
Ongoing | 2020-005626-29 | A phase II study on trabectedin in combination with PPARg agonist pioglitazone in patients with round cell myxoid liposarcomas or dedifferentiated G1 and G2 liposarcomas with stable disease after a mo... | not-yet-due | |
Ongoing | 2021-000726-10 | Evaluating the short-term renal and systemic effects of Dapagliflozin in non-diabetic patients with stage IV CKD at risk of ESKD because of severe renal insufficiency and persistent proteinuria: A pro... | not-yet-due | |
Ongoing | 2021-000835-30 | RESCUE THERAPY WITH THE HUMAN ANTI-CD38 ANTIBODY MOR202 (FELZARTAMAB) IN PATIENTS WITH MEMBRANOUS NEPHROPATHY WHO FAILED ANTI-CD20 TARGETED THERAPY: A PILOT, PROOF-OF-CONCEPT STUDY “Rescue therap... | not-yet-due | |
Ongoing | 2021-004864-81 | Proposta di studio per valutare l’efficacia di Obinutuzumab, un anticorpo anti-CD20, in pazienti con nefropatia membranosa intolleranti, resistenti o dipendenti alla terapia con Rituximab (studio ORIO... | not-yet-due |